In a new strategic collaboration, Atinary Technologies is integrating its automated, no-code AI-driven process optimization technology with the state-of-the-art labs and process development capabilities of Snapdragon Chemistry to address the complex challenges of drug development. Thanks to the collaboration, the new customer from the US East Coast was already able to present impressive results.
Biopôle-based Atinary Technologies, whose leading no-code AI platform, SDLabsTM, and Self-Driving LabsTM technology are transforming research and development (R&D) of new molecules and chemicals, announces a strategic collaboration with Snapdragon Chemistry, a Cambrex company. Snapdragon is a recognized leader in active pharmaceutical ingredient (API) process development, with specialization in continuous flow process development, lab automation and complex synthetic APIs.
Through this collaboration, Snapdragon integrated its proprietary LabOSTM software platform with Atinary’s SDLabsTM platform to build a fully automated and AI-driven, medium-throughput Solid-Phase Oligonucleotide Synthesizer (SPOS) for the purpose of autonomous multi-objective process optimizations. By using Atinary’s AI platform, Snapdragon’s process optimization campaign has demonstrated significant improvements across the tested applications, with up to an 18% increase in product yield and a 22% reduction in cost compared to processes previously optimized by an experienced scientist.
"Atinary is committed to accelerating innovation and delivering cutting-edge solutions to our customers," said Dr. Hermann Tribukait, Co-Founder and CEO of Atinary Technologies. "Our work with Snapdragon showcases the power of our AI and data-driven process to solve complex chemistry and molecular discovery challenges in the pharmaceutical and biotech industry, orders of magnitude faster than traditional methods."
Snapdragon’s state-of-the-art laboratories and process development capabilities, along with their ability to design and build self-contained reactors, will be instrumental in this collaboration.
Promising first results
Contacted by Startupticker.ch, Edlyn Wu, Business Developer at Atinary, explains that the start-up’s East-Coast customer Snapdragon combined its LabOS software platform with Atinary's SDLabs platform to build its fully automated, AI-driven, mid-throughput solid-phase oligonucleotide synthesizer (SPOS). Through Atinary’s AI platform, Snapdragon’s process optimization campaign has demonstrated significant improvements across the tested applications, with up to an 18% increase in product yield and a 22% reduction in cost compared to processes previously optimized by an experienced scientist. Snapdragon also incorporates Atinary's platform into their R&D workflows, streamlining and expediting drug development pipelines and R&D portfolio.
(PR - ES)
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
Please login or sign up to comment.
Commenting guidelines